Open Payments

York Hospital

Type
Teaching hospital
Where
York, PA
Medicare CCN
390046
Received
$219,263 in 209 records, 2020 ($57,004 general, $162,258 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment27$57,004
2020Research payment182$162,258

By company

CompanyRecordsAmountYears
Edwards Lifesciences Corporation20$67,8182020
Stryker Corporation24$51,2432020
Boehringer Ingelheim International GmbH95$20,6502020
Zogenix Inc.3$18,4472020
Becton, Dickinson and Company2$12,6262020
Boehringer Ingelheim Pharma GmbH & Co.KG3$9,6572020
Pharmacyclics LLC, an AbbVie Company46$9,1502020
Incyte Corporation2$8,8912020
GW Research Limited2$5,3272020
TriReme Medical LLC3$5,3002020
Boston Scientific Corporation4$3,4282020
Aesculap, Inc.1$2,9422020
Medtronic Vascular, Inc.1$2,5952020
Bolton Medical Inc1$5002020
Eli Lilly and Company1$4622020
Masimo Corporation1$2232020

By nature of payment

NatureRecordsAmount
Research payment182$162,258
Gift9$49,029
Compensation for services other than consulting, including serving as faculty or as a speaker at a v16$5,157
Grant1$2,595
Education1$223

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-23Edwards Lifesciences Corporation$500Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPartner3 2015-082020
2020-12-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-17Edwards Lifesciences Corporation$11,993Research paymentCash or cash equivalentEarly-TAVR Trial #2016-072020
2020-12-17Edwards Lifesciences Corporation$500Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER3 2015-082020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-12-10Aesculap, Inc.$2,942GiftCash or cash equivalent2020
2020-12-08TriReme Medical LLC$2,100Research paymentCash or cash equivalentBALLOON CATHETER Device, BALLOON CATHETERBALLOON CATHETER2020
2020-12-07Edwards Lifesciences Corporation$144Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-11-16Boston Scientific Corporation$500Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-11-05Boehringer Ingelheim International GmbH$1Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-10-26Edwards Lifesciences Corporation$144Research paymentCash or cash equivalentPartner3 2015-082020
2020-10-22Edwards Lifesciences Corporation$10,042Research paymentCash or cash equivalentEarly-TAVR Trial #2016-072020
2020-10-13Stryker Corporation$946Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-10-13Stryker Corporation$354Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-10-13Stryker Corporation$74Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-10-13Stryker Corporation$31Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-10-02Boehringer Ingelheim International GmbH$21Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-10-02Boehringer Ingelheim International GmbH$0Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-10-02Boehringer Ingelheim International GmbH$0Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-10-01Edwards Lifesciences Corporation$1,091Research paymentCash or cash equivalentPartner3 2015-082020
2020-10-01Edwards Lifesciences Corporation$226Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-10-01Edwards Lifesciences Corporation$141Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-10-01Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-09-28Edwards Lifesciences Corporation$1,214Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesEarly-TAVR Trial #2016-072020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-09-21Boston Scientific Corporation$176Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-09-17Boehringer Ingelheim International GmbH$2,601Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-09-14TriReme Medical LLC$800Research paymentCash or cash equivalentBALLOON CATHETER Device, BALLOON CATHETERBALLOON CATHETER2020
2020-09-09Becton, Dickinson and Company$6,012Research paymentCash or cash equivalentBD Veritor Device, Diagnostic SystemsVeritor Antigen Assay2020
2020-08-31Boehringer Ingelheim Pharma GmbH & Co.KG$3,049Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-08-26Boehringer Ingelheim International GmbH$842Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-08-25Pharmacyclics LLC, an AbbVie Company$2,500Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-08-24Edwards Lifesciences Corporation$11,077Research paymentCash or cash equivalentEarly-TAVR Trial #2016-072020
2020-08-20Zogenix Inc.$4,879Research paymentCash or cash equivalentZX008 Drug, Treatment of seizuresA Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Childre2020
2020-08-20Zogenix Inc.$781Research paymentCash or cash equivalentZX008 Drug, Treatment of seizuresA Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Childre2020
2020-08-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-08-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-08-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-08-05Becton, Dickinson and Company$6,614Research paymentIn-kind items and servicesBD Veritor Device, Diagnostic SystemsVeritor Antigen Assay2020
2020-07-31Boehringer Ingelheim Pharma GmbH & Co.KG$3,558Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-07-24Boehringer Ingelheim International GmbH$2,303Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-07-24Boehringer Ingelheim International GmbH$504Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-07-24Boehringer Ingelheim International GmbH$282Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-07-24Boehringer Ingelheim International GmbH$261Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-07-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-07-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-07-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-07-16Zogenix Inc.$12,787Research paymentCash or cash equivalentZX008 Drug, Treatment of seizuresA Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Childre2020
2020-07-09Edwards Lifesciences Corporation$226Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-07-07Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-07-06Stryker Corporation$459Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-07-06Stryker Corporation$127Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-07-06Stryker Corporation$44Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-07-06Stryker Corporation$29Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-07-03Boehringer Ingelheim International GmbH$21Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-07-03Boehringer Ingelheim International GmbH$18Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-07-03Boehringer Ingelheim International GmbH$18Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-07-03Boehringer Ingelheim International GmbH$9Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-07-02Edwards Lifesciences Corporation$9,040Research paymentCash or cash equivalentPARTNER3 2015-082020
2020-07-01Boehringer Ingelheim International GmbH$282Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-06-16Boehringer Ingelheim International GmbH$956Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-06-16Boehringer Ingelheim International GmbH$956Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-06-16Boehringer Ingelheim International GmbH$956Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-16Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-06-10Medtronic Vascular, Inc.$2,595GrantIn-kind items and servicesIN.PACT AV Device, Drug-Coated Balloons2020
2020-06-05GW Research Limited$2,898Research paymentCash or cash equivalentGWEP15212020
2020-06-01Stryker Corporation$10,190GiftIn-kind items and servicesINTOUCH W/ZOOM Device, PATIENT CARE - PC2020
2020-06-01Stryker Corporation$10,190GiftIn-kind items and servicesINTOUCH W/ZOOM Device, PATIENT CARE - PC2020
2020-06-01Stryker Corporation$10,190GiftIn-kind items and servicesINTOUCH W/ZOOM Device, PATIENT CARE - PC2020
2020-06-01Stryker Corporation$4,716GiftIn-kind items and servicesISOLIBRIUM Device, PATIENT CARE - PC2020
2020-06-01Stryker Corporation$4,716GiftIn-kind items and servicesISOLIBRIUM Device, PATIENT CARE - PC2020
2020-06-01Stryker Corporation$4,716GiftIn-kind items and servicesISOLIBRIUM Device, PATIENT CARE - PC2020
2020-05-26Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-05-26Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-05-26Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-05-22Boehringer Ingelheim International GmbH$1,774Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$887Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$693Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$693Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$693Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$282Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$59Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$47Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$17Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-22Boehringer Ingelheim International GmbH$17Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-05-12Boehringer Ingelheim International GmbH$693Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-06Bolton Medical Inc$500Research paymentCash or cash equivalentTreovance Device, DeviceTreovance2020
2020-05-04Boehringer Ingelheim International GmbH$40Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$25Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-05-01Stryker Corporation$894Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-05-01Stryker Corporation$371Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-05-01Stryker Corporation$109Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-05-01Stryker Corporation$32Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-04-20Boehringer Ingelheim International GmbH$141Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-14Boehringer Ingelheim International GmbH$956Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-09Edwards Lifesciences Corporation$7,480Research paymentCash or cash equivalentEarly-TAVR Trial #2016-072020
2020-04-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-01Boehringer Ingelheim International GmbH$336Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-04-01Masimo Corporation$223EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-04-01Edwards Lifesciences Corporation$194Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPartner3 2015-082020
2020-03-23Edwards Lifesciences Corporation$432Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-03-19Edwards Lifesciences Corporation$500Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesEarly-TAVR Trial #2016-072020
2020-03-18Boston Scientific Corporation$638Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-03-17Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-03-17Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-03-17Pharmacyclics LLC, an AbbVie Company$50Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-03-09Edwards Lifesciences Corporation$9,067Research paymentCash or cash equivalentPartner3 2015-082020
2020-03-06Edwards Lifesciences Corporation$3,300Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER II (2010-12)2020
2020-03-06Edwards Lifesciences Corporation$500Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPartner3 2015-082020
2020-03-03Boehringer Ingelheim International GmbH$61Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-03-03Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-03-03Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-03-03Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-26Incyte Corporation$3,500Research paymentCash or cash equivalentEvaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S2020
2020-02-25Boehringer Ingelheim International GmbH$796Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-25Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-18Boston Scientific Corporation$2,114Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-02-14Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-13Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-02-13Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentImbruvica Drug, OncologyPCYC-1134M-CA2020
2020-02-05Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-05Boehringer Ingelheim International GmbH$26Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-05Boehringer Ingelheim International GmbH$25Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-05Boehringer Ingelheim International GmbH$23Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-05Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-05Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-05Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-02-05Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-05Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-05Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-02-05Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-31Boehringer Ingelheim Pharma GmbH & Co.KG$3,049Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-28Eli Lilly and Company$462Research paymentIn-kind items and servicesA RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD2020
2020-01-28Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-22Incyte Corporation$5,391Research paymentCash or cash equivalentEvaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S2020
2020-01-22GW Research Limited$2,429Research paymentCash or cash equivalentGWEP15212020
2020-01-20TriReme Medical LLC$2,400Research paymentCash or cash equivalentBALLOON CATHETER Device, BALLOON CATHETERBALLOON CATHETER2020
2020-01-14Stryker Corporation$1,190Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-01-14Stryker Corporation$932GiftIn-kind items and servicesINTOUCH W/ZOOM Device, PATIENT CARE - PC2020
2020-01-14Stryker Corporation$431GiftIn-kind items and servicesISOLIBRIUM Device, PATIENT CARE - PC2020
2020-01-14Stryker Corporation$323Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-01-14Stryker Corporation$137Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-01-14Stryker Corporation$29Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2020
2020-01-06Boehringer Ingelheim International GmbH$65Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$52Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-01-06Boehringer Ingelheim International GmbH$41Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-01-06Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-01-06Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$26Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020
2020-01-06Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2020
2020-01-06Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2020

The latest 200 records of 209.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

York CountyYork city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In York, PA, county York County, PA, state Pennsylvania; placed by its city name.

MeasurePlace (city or town)
York, PA
County
York County, PA
State
Pennsylvania
Population B0100344,938462,92413,018,639
Population, 2020 census P144,800456,43813,002,700
Median age B0100234.341.140.9
Under 18 B0100123.9%21.9%20.4%
65 and over B0100113.1%18.8%19.5%
Households B1100117,893181,5835,274,853
Foreign born B0500211.1%4.1%7.7%
Median household income B19013$48,420$84,829$77,971
Median family income B19113$54,727$102,186$100,262
Per capita income B19301$26,308$41,601$44,355
Poverty rate B1700121.1%8.4%11.7%
Unemployment rate B2302510.7%4.5%5.3%
Civilian labor force B2302523,179245,6936,684,175
Mean commute (minutes) B0801323.126.326.3
Bachelor's degree or higher B1500317.5%27.6%35.2%
Housing units B2500119,505189,8575,806,452
Owner-occupied B2500343.7%76.3%69.3%
Renters B2500356.3%23.7%30.7%
Median home value B25077$119,700$248,600$254,500
Median gross rent B25064$1,014$1,193$1,209
White, not Hispanic B0300233.6%78.9%73.0%
Black B0300224.1%5.8%10.3%
Hispanic or Latino B0300236.6%9.6%8.7%
Asian B030021.0%1.5%3.8%
American Indian and Alaska Native B030020.0%0.0%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in York, PA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.